• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

磁共振成像在甲状腺相关性眼病疾病活动度评估中的作用

Role of magnetic resonance imaging in the assessment of disease activity in thyroid-associated ophthalmopathy.

作者信息

Yokoyama Naokata, Nagataki Shigenobu, Uetani Masataka, Ashizawa Kiyoto, Eguchi Katsumi

机构信息

Department of Internal Medicine, Oita National Hospital, Japan.

出版信息

Thyroid. 2002 Mar;12(3):223-7. doi: 10.1089/105072502753600179.

DOI:10.1089/105072502753600179
PMID:11952043
Abstract

Two different phases in disease activity are observed during the clinical course of thyroid-associated ophthalmopathy (TAO). The assessment of disease activity is important for predicting the outcome of medical management because medical treatment can be effective in the active stage. The aim of this study was to investigate whether magnetic resonance imaging (MRI) could assess the disease activity in TAO. To investigate the relation between MRI-T2 signal intensity (SI) and extraocular muscle (EOM) size, 11 patients with TAO were evaluated. EOM sizes (enlargement, volume) were measured by MRI-T1 image. T2-SI of EOM was expressed as a percentage of temporal muscle. The reduction in T2-SI was significantly positively correlated with that of EOM enlargement after treatment. Additionally, T2-SI in pretreatment showed a significant correlation with reduction in EOM volume for therapeutic effect, which indicates T2-SI in pretreatment can be one of the reliable parameters for predicting the therapeutic outcome of treatment. To investigate whether MRI-T2 pattern could predict the reversibility of diplopia, 28 patients with Graves' disease with or without ophthalmopathy were evaluated. Patients with TAO with reversible diplopia showed an uniform T2 pattern in enlarged EOM. However, in patients with irreversible diplopia caused by the mechanical limitation of EOM, MRI-T2 image showed no uniformity with a partial appearance of low T2-SI. The partial low T2-SI may indicate the progress of inactive (fibrotic) change in EOM after active (inflammatory) change. In conclusion, MRI is a useful tool for detection not only of EOM enlargement, but also disease activity in TAO. MRI-T2 SI and pattern can predict the outcome of medical management in TAO.

摘要

在甲状腺相关性眼病(TAO)的临床病程中观察到疾病活动的两个不同阶段。疾病活动度的评估对于预测药物治疗的结果很重要,因为药物治疗在活动期可能有效。本研究的目的是调查磁共振成像(MRI)是否可以评估TAO的疾病活动度。为了研究MRI-T2信号强度(SI)与眼外肌(EOM)大小之间的关系,对11例TAO患者进行了评估。通过MRI-T1图像测量EOM大小(增大、体积)。EOM的T2-SI表示为颞肌的百分比。治疗后T2-SI的降低与EOM增大的降低显著正相关。此外,治疗前的T2-SI与EOM体积减少的治疗效果显著相关,这表明治疗前的T2-SI可以作为预测治疗效果的可靠参数之一。为了研究MRI-T2模式是否可以预测复视的可逆性,对28例患有或未患有眼病的格雷夫斯病患者进行了评估。TAO伴有可逆性复视的患者在增大的EOM中表现出均匀的T2模式。然而,在由EOM机械性限制导致的不可逆复视患者中,MRI-T2图像显示不均匀,部分出现低T2-SI。部分低T2-SI可能表明活动期(炎症)改变后EOM中不活动(纤维化)改变的进展。总之,MRI不仅是检测EOM增大的有用工具,也是检测TAO疾病活动度的有用工具。MRI-T2 SI和模式可以预测TAO的药物治疗结果。

相似文献

1
Role of magnetic resonance imaging in the assessment of disease activity in thyroid-associated ophthalmopathy.磁共振成像在甲状腺相关性眼病疾病活动度评估中的作用
Thyroid. 2002 Mar;12(3):223-7. doi: 10.1089/105072502753600179.
2
[The value of DCE-MRI in assessing the course of thyroid associated ophthalmopathy].[动态对比增强磁共振成像在评估甲状腺相关性眼病病程中的价值]
Zhonghua Yan Ke Za Zhi. 2017 Jun 11;53(6):430-435. doi: 10.3760/cma.j.issn.0412-4081.2017.06.007.
3
Magnetic resonance imaging and ultrasound measurements of extraocular muscles in thyroid-associated ophthalmopathy at different stages of the disease.甲状腺相关性眼病不同疾病阶段眼外肌的磁共振成像和超声测量
Acta Ophthalmol Scand. 2007 Mar;85(2):192-201. doi: 10.1111/j.1600-0420.2006.00807.x.
4
Untreated Graves' disease patients without clinical ophthalmopathy demonstrate a high frequency of extraocular muscle (EOM) enlargement by magnetic resonance.未经治疗且无临床眼病的格雷夫斯病患者,通过磁共振成像显示眼外肌(EOM)增大的频率较高。
J Clin Endocrinol Metab. 1995 Sep;80(9):2830-3. doi: 10.1210/jcem.80.9.7673432.
5
Magnetic resonance imaging determination of extraocular eye muscle volume in patients with thyroid-associated ophthalmopathy and proptosis.磁共振成像测定甲状腺相关性眼病和眼球突出患者的眼外肌体积
Acta Ophthalmol Scand. 2006 Jun;84(3):419-23. doi: 10.1111/j.1600-0420.2005.00617.x.
6
Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: its predictive value for therapeutic outcome of immunosuppressive therapy.磁共振成像在甲状腺相关性眼病中的作用:其对免疫抑制治疗疗效的预测价值
Thyroid. 1992 Winter;2(4):299-305. doi: 10.1089/thy.1992.2.299.
7
Graves' ophthalmopathy: eye muscle involvement in patients with diplopia.格雷夫斯眼病:复视患者的眼肌受累情况
Eur J Endocrinol. 2000 Jun;142(6):591-7. doi: 10.1530/eje.0.1420591.
8
Low signal intensities of MRI T1 mapping predict refractory diplopia in Graves' ophthalmopathy.MRI T1 映射低信号强度可预测格雷夫斯眼病的难治性复视。
Clin Endocrinol (Oxf). 2020 Jun;92(6):536-544. doi: 10.1111/cen.14178. Epub 2020 Mar 5.
9
Usefulness of two-point Dixon T2-weighted imaging in thyroid-associated ophthalmopathy: comparison with conventional fat saturation imaging in fat suppression quality and staging performance.两点 Dixon T2 加权成像在甲状腺相关眼病中的应用:与常规脂肪抑制成像在脂肪抑制质量和分期性能方面的比较。
Br J Radiol. 2021 Feb 1;94(1118):20200884. doi: 10.1259/bjr.20200884. Epub 2020 Dec 22.
10
Prediction of treatment response to intravenous glucocorticoid in patients with thyroid-associated ophthalmopathy using T2 mapping and T2 IDEAL.使用 T2 映射和 T2 IDEAL 预测甲状腺相关眼病患者静脉注射糖皮质激素的治疗反应。
Eur J Radiol. 2021 Sep;142:109839. doi: 10.1016/j.ejrad.2021.109839. Epub 2021 Jul 3.

引用本文的文献

1
Application progress of magnetic resonance imaging in thyroid associated ophthalmopathy.磁共振成像在甲状腺相关性眼病中的应用进展
Front Endocrinol (Lausanne). 2025 Jun 26;16:1537957. doi: 10.3389/fendo.2025.1537957. eCollection 2025.
2
TOM500: A Multi-Organ Annotated Orbital MRI Dataset for Thyroid Eye Disease.TOM500:一个用于甲状腺眼病的多器官注释眼眶磁共振成像数据集
Sci Data. 2025 Jan 13;12(1):60. doi: 10.1038/s41597-025-04427-9.
3
Whole-orbit radiomics: machine learning-based multi- and fused- region radiomics signatures for intravenous glucocorticoid response prediction in thyroid eye disease.
全眼眶放射组学:基于机器学习的多区域和融合区域放射组学特征,用于预测甲状腺眼病静脉内糖皮质激素治疗反应。
J Transl Med. 2024 Jan 13;22(1):56. doi: 10.1186/s12967-023-04792-2.
4
Observation study of using a small dose of rituximab treatment for thyroid-associated ophthalmopathy in seven Chinese patients: One pilot study.观察研究:小剂量利妥昔单抗治疗 7 例中国甲状腺相关眼病患者的疗效:一项初步研究。
Front Endocrinol (Lausanne). 2023 Jan 18;13:1079852. doi: 10.3389/fendo.2022.1079852. eCollection 2022.
5
Correlation Analysis between Intraocular Pressure and Extraocular Muscles Based on Orbital Magnetic Resonance T2 Mapping in Thyroid-Associated Ophthalmopathy Patients.基于眼眶磁共振T2成像的甲状腺相关性眼病患者眼压与眼外肌的相关性分析
J Clin Med. 2022 Jul 8;11(14):3981. doi: 10.3390/jcm11143981.
6
Extraocular muscle enlargement.眼外肌肿大。
Graefes Arch Clin Exp Ophthalmol. 2022 Nov;260(11):3419-3435. doi: 10.1007/s00417-022-05727-1. Epub 2022 Jun 17.
7
Insights into Current Management Strategies for Dysthyroid Optic Neuropathy: A Review.甲状腺功能异常性视神经病变当前管理策略的见解:综述
Clin Ophthalmol. 2022 Mar 18;16:841-850. doi: 10.2147/OPTH.S284609. eCollection 2022.
8
Texture analysis of orbital magnetic resonance imaging for monitoring and predicting treatment response to glucocorticoids in patients with thyroid-associated ophthalmopathy.甲状腺相关眼病患者眼眶磁共振成像的纹理分析用于监测和预测对糖皮质激素的治疗反应
Endocr Connect. 2021 Jun 24;10(7):676-684. doi: 10.1530/EC-21-0162.
9
Baseline Volumetric T2 Relaxation Time Histogram Analysis: Can It Be Used to Predict the Response to Intravenous Methylprednisolone Therapy in Patients With Thyroid-Associated Ophthalmopathy?基线容积 T2 弛豫时间直方图分析:能否用于预测甲状腺相关眼病患者静脉注射甲泼尼龙治疗的反应?
Front Endocrinol (Lausanne). 2021 Feb 25;12:614536. doi: 10.3389/fendo.2021.614536. eCollection 2021.
10
Histogram analysis of T2 mapping for detecting early involvement of extraocular muscles in patients with thyroid-associated ophthalmopathy.T2 映射直方图分析检测甲状腺相关眼病患者眼外肌早期受累。
Sci Rep. 2020 Nov 10;10(1):19445. doi: 10.1038/s41598-020-76341-6.